Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-06-25

Clinical Trial Update: Assesment of the Efficiency and Safety Helicobacter Pylori Therapy With or Without Saccharomyces Boulardii [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating the efficacy and safety of Helicobacter pylori therapy with or without Saccharomyces boulardii.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Saccharomyces boulardii (Saccharomyces boulardii)

Snippet

Sponsor: Clinical Centre of Serbia | Conditions: Helicobacter Pylori Infection | Phase 4 | Status: UNKNOWN